Likely active: portfolio news Mar 2026 Verified 5 Nov 2026
Syncona
FTSE 250 listed investment company, managed by Syncona Investment Management Limited, that founds, builds and funds life science companies from pre-clinical to commercial stage.
- Type
- VC firm
- Location
- London, United Kingdom
- Stages
- Seed, Series A, Series B, Growth
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences
- Website
- www.synconaltd.com
Contacts on file
For Syncona, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
Autolus TherapeuticsBeacon TherapeuticsQuell TherapeuticsOMass TherapeuticsRe-Aim Therapeutics
Sources
- www.synconaltd.com/
- www.synconaltd.com/our-people
- www.synconaltd.com/portfolio/pre-clinical-companies
- www.synconaltd.com/portfolio/late-stage-clinical-companies
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 26 lists
Biotech investors in London (42)Series B investors in the UK (54)Series B biotech investors (73)Biotech investors in the UK (92)Growth-stage biotech investors (109)Healthtech investors in London (113)Growth-stage investors in the UK (137)Venture capital firms in London (149)Series A biotech investors (153)Series A investors in the UK (154)Series B healthtech investors (160)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Startup investors in London (239)Seed investors in the UK (295)Seed biotech investors (300)Growth-stage healthtech investors (316)Series B investors (339)Series A healthtech investors (401)Startup investors in the UK (416)Biotech investors (484)Growth-stage investors (705)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)